(Bloomberg) -- US regulators are investigating the death of an 8-year-old boy in Brazil who received Sarepta Therapeutics Inc.’s Elevidys. The death occurred on June 7, according to a statement from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback